Markets › LSE › SN.L

Smith & Nephew plc

LSE:SN.LHealthcareFTSE:ASXFTSE:NMX

£10.87+0.79%At closeAt close · Tue 20 Oct · ≈ AED 53.17 · Market cap $12.18B · Next earnings Tue 23 Feb

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	69.4%	70.4%	70.5%	68.8%	69.6%	68.0%	—	—
Operating margin	6.5%	11.4%	6.0%	7.7%	11.3%	16.3%	16.3%	+0.0 pts
Net margin	9.8%	10.1%	4.3%	4.7%	7.1%	10.1%	10.1%	+0.0 pts
EBITDA margin	19.0%	23.8%	16.8%	17.2%	21.3%	25.6%	—	—
Return on equity	8.5%	9.4%	4.2%	5.0%	7.8%	12.1%	12.1%	+0.0 pts
Return on assets	4.1%	4.8%	2.2%	2.6%	4.0%	6.1%	6.1%	+0.0 pts
Return on capital employed	3.2%	6.7%	3.8%	5.5%	7.4%	11.6%	—	—
Debt / equity	0.7×	0.6×	0.5×	0.6×	0.6×	0.6×	0.6×	+0.0%
Debt / assets	33.5%	30.6%	28.8%	30.9%	32.1%	31.8%	—	—
Interest coverage	4.8×	7.4×	3.9×	3.1×	3.9×	6.4×	—	—
Current ratio	2.8×	2.1×	2.2×	1.8×	2.9×	2.6×	2.6×	+0.0%
Quick ratio	1.8×	1.2×	1.0×	0.7×	1.3×	1.2×	—	—
Cash ratio	1.0×	0.6×	0.2×	0.1×	0.4×	0.3×	0.3×	+0.0%
Asset turnover	0.4×	0.5×	0.5×	0.6×	0.6×	0.6×	—	—
Inventory turnover	0.8×	0.8×	0.7×	0.7×	0.7×	1.0×	—	—
Receivables turnover	5.0×	5.4×	5.1×	5.2×	4.8×	4.4×	—	—
Dividend payout	73.2%	62.8%	146.6%	124.3%	79.4%	52.8%	—	—